Deep vein thrombosis resolution is impaired in diet-induced type 2 diabetic mice

Journal of Vascular Surgery

Volumn 48, Issue 6, 2008, Pages 1575-1584

  Bouzeghrane, Fatiha ^a   Zhang, Xiaochun ^a   Gevry, Guylaine ^a   Raymond, Jean ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE A; GELATINASE B; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFERIOR CAVA VEIN; LIPID DIET; LOW FAT DIET; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBUS; WESTERN BLOTTING;

EID: 57949115363     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.07.050     Document Type: Article

References (44)

1. Jones E.W., and Mitchell J.R.A. Venous thrombosis in diabetes mellitus. Diabetologia 25 (1983) 502-505
2. Lowe G.D.O. Arterial disease and venous thrombosis: are they related, and if so, what should we do about it?. J ThrombHaemost 4 (2006) 1882-1885
3. Agnelli G., and Becattini C. Venous thromboembolism and atherosclerosis: common denominators or different diseases?. J Thromb Haemost 4 (2006) 1886-1890
4. Petrauskiene V., Falk M., Waernbaum I., Norberg M., and Eriksson J.W. The risk of venous thromboembolism is markedly elevated in patients with diabetes. Diabetologia 48 (2005) 1017-1021
5. Stein P.D., Afzal Beemath A., and Olson R.E. Obesity as a risk factor in venous thromboembolism. Am J Med 118 (2005) 978-980
6. Ali T., Humphries J., Burnand K., Sawyer B., Bursill C., Channon K., et al. Monocyte recruitment in venous thrombus resolution. J Vasc Surg 43 (2006) 601-608
7. Northeast A.D., Soo K.S., Bobrow L.G., Gafnee P.J., and Bernand K.G. The tissue plasminogen activator and urokinase response in vivo during natural resolution of venous thrombosis. J Vasc Surg 22 (1995) 573-579
8. Wakefield T.W., Linn M.J., Henke P.K., Kadell A.M., Wilke C.A., Wrobleski S.K., et al. Neovascularization during venous thrombosis organization: A preliminary study. J Vasc Surg 30 (1999) 885-893
9. Deatrick K.B., Eliason J.L., Lynch E.M., Moore A.J., Dewyer N.A., Varma M.R., et al. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model. J Vasc Surg 42 (2005) 140-148
10. Singh I., Burnand K.G., Collins M., Luttun A., Collen D., Boelhouwer B., et al. Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells. Circulation 107 (2003) 869-875
11. McGuinness C.L., Humphries J., Waltham M., Burnand K.G., Collins M., and Smith A. Recruitment of labelled monocytes by experimental venous thrombi. Thromb Haemost 85 (2001) 1018-1024
12. Modarai B., Burnand K.G., Humphries J., Waltham M., and Smith A. The role of neovascularisation in the resolution of venous thrombus. Thromb Haemost 93 (2005) 801-809
13. Surwit R.S., Kuhn C.M., Cochrane C., McCubbin J.A., and Feinglos M.N. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37 (1988) 1163-1167
14. Collins S., Martin T.L., Surwit R.S., and Robidoux J. Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav 81 (2004) 243-248
15. Molnar J., Yu S., Mzhavia N., Pau C., Chereshnev I., and Dansky H.M. Diabetes induces endothelial dysfunction but does not increase neointimal formation in high-fat diet fed C57BL/6J mice. Circ Res 96 (2005) 1178-1184
16. Schreyer S.A., Vick C., Lystig T.C., Mystkowski P., and LeBoeuf R.C. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am J Physiol Endocrinol Metab 282 (2002) E207-E214
17. Schreyer S.A., Wilson D.L., and LeBoeuf R.C. C57BL/6 mice fed high-fat diets as models for diabetes-accelerated atherosclerosis. Atherosclerosis 136 (1998) 17-24
18. Juhan-Vague I.M., Alessi C., and Vague P. Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus. Ann Med 28 (1996) 371-380
19. Pandolfi A., Cetrullo D., Polishuck R., Alberta M.M., Calafiore A., Pellegrini G., et al. Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects. Arterioscler Thromb Vasc Biol 21 (2001) 1378-1382
20. Raymond J., Guilbert F., Metcalfe A., Gevry G., Salazkin I., and Robledo O. Role of the endothelial lining in recurrences after coil embolization: prevention of recanalization by endothelial denudation. Stroke 35 (2004) 1471-1475
21. Bouzeghrane F., Darsaut T., Salazkin I., Ogoudikpe C., Gevry G., and Raymond J. MMP-9 may play a role in recanalization and recurrence after therapeutic embolization of aneurysms or arteries. J Vasc Interv Radiol 18 (2007) 1271-1279
22. Junqueira L.C., Bignolas G., and Brentani R.R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11 (1979) 447-455
23. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 444 (2006) 860-867
24. De Souza C.T., Araujo E.P., Bordin S., Ashimine R., Zollner R.L., and Boschero A.C. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146 (2005) 4192-4199
25. Barbato J.E., Zuckerbraun B.S., Overhaus M., Raman K.G., and Tzeng E. Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and the metabolic syndrome. Am J Physiol Heart Circ Physiol 289 (2005) H228-H236
26. Waltenberger J., Lange J., and Kranz A. Vascular endothelial growth factor-a-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: a potential predictor for the individual capacity to develop collaterals. Circulation 102 (2000) 185-190
27. Marx N., Neumann F.J., Zohlnhöfer D., Dickfeld T., Fischer A., Heimerl S., et al. Enhancement of monocyte procoagulant activity by adhesion on vascular smooth muscle cells and intercellular adhesion molecule-1-transfected Chinese hamster ovary cells. Circulation 98 (1998) 906-911
28. Lundgren C.H., Sawa H., Soble B.E., and Fujii S. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy. Circulation 90 (1994) 1927-1934
29. Ma L.J., Mao S.L., Taylor K.L., Kanjanabuch T., Guan Y., Zhang Y., et al. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes 53 (2004) 336-346
30. Smith L.H., Dixon J.D., Stringham J.R., Eren M., Elokdah H., Crandall D.L., et al. Pivotal role of PAI-1 in a murine model of hepatic vein thrombosis. Blood 107 (2006) 132-134
31. Hayden M.R., Sowers J.R., and Tyagi S.C. The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: the matrix preloaded. Cardiovasc Diabetol 28 (2005) 4-9
32. Mompeo B., Ortega F., Sarmiento L., and Castano I. Ultrastructural analogies between intimal alterations in veins from diabetic patients and animals with STZ-induced diabetes. Ann Vasc Surg 13 (1999) 294-301
33. Kadoglou N.P., Daskalopoulou S.S., Perrea D., and Liapis C.D. Matrix metalloproteinases and diabetic vascular complications. Angiology 56 (2005) 173-189
34. van Hinsbergh Victor W.M., Engelse Marten A., and Quax Paul H.A. Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol 26 (2006) 716-728
35. Morishige K., Shimokawa H., Matsumoto Y., Eto Y., Uwatoku T., Abe K., et al. Overexpression of matrix metalloproteinase-9 promotes intravascular thrombus formation in porcine coronary arteries in vivo. Cardiovasc Res 57 (2003) 572-585
36. Ryan M.E., Usman A., Ramamurthy N.S., Golub L.M., and Greenwald R.A. Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity. Curr Med Chem 8 (2001) 305-316
37. Santos-Martínez M.J., Medina C., Jurasz P., and Radomski M.W. Role of metalloproteinases in platelet function. Thromb Res 121 (2008) 535-542
38. Newby A.C. Dual role of matrix metalloproteinases (Matrixins) in intimal thickening of atherosclerotic plaque rupture. Physiol Rev 85 (2005) 1-31
39. Dewyer N.A., Sood V., Lynch E.M., Luke C.E., Upchurch Jr. G.R., Wakefield T.W., et al. Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution. J Surg Res 142 (2007) 357-363
40. Vaidyula V.R., Rao A.K., Mozzoli M., Homko C., Cheung P., and Boden G. Effects of hyperglycaemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand. Diabetes 55 (2006) 202-208
41. Stegenga M.E., van der Crabben S.N., Levi M., de Vos A.F., Tanck M.W., Sauerwein H.P., et al. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes 55 (2006) 1807-1812
42. Hansen H.R., Wolfs J.L., Bruggemann L., Sommeijer D.W., Bevers E., Hauer A.D., et al. Hyperglycemia accelerates arterial thrombus formation and attenuates the antithrombotic response to endotoxin in mice. Blood Coagul Fibrinolysis 18 (2007) 627-636
43. Hatanaka E., Monteagudo P.T., Marrocos M.S., and Campa A. Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clin Exp Immunol 146 (2006) 443-447
44. Oya-Ito T., Naitou H., Masuda S., Kinae N., and Ohashi N. Functional analyses of neutrophil-like differentiated cell lines under a hyperglycemic condition. Mol Nutr Food Res 52 (2008) 360-369